Consolidated Portfolio Review Corp’s FT Vest US Equity Enhance & Moderate Buffer ETF March XMAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,600
Closed -$377K 444
2025
Q3
$377K Buy
9,600
+1,136
+13% +$44K 0.05% 320
2025
Q2
$324K Buy
+8,464
New +$313K 0.04% 335

Other funds holding XMAR

Consolidated Portfolio Review Corp's XMAR Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of FT Vest US Equity Enhance & Moderate Buffer ETF March (XMAR) in Q4 2025, closing a stake of 9,600 shares — an estimated $377K sold.

Consolidated Portfolio Review Corp first reported a position in XMAR in Q2 2025 and held it in 2 quarters. The position peaked at $377K in Q3 2025. 70 funds tracked by Wall St. Rank hold XMAR as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining FT Vest US Equity Enhance & Moderate Buffer ETF March position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 9,600 FT Vest US Equity Enhance & Moderate Buffer ETF March shares in Q4 2025, an estimated $377K.
  • Consolidated Portfolio Review Corp first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF March in Q2 2025 and held it in 2 quarters.
  • Consolidated Portfolio Review Corp's FT Vest US Equity Enhance & Moderate Buffer ETF March position peaked at $377K in Q3 2025.
  • 70 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF March as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.